Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Receivables (2023 - 2025)

Historic Receivables for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $515000.0.

  • CG Oncology's Receivables rose 27591.24% to $515000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $515000.0, marking a year-over-year increase of 27591.24%. This contributed to the annual value of $92000.0 for FY2023, which is N/A changed from last year.
  • Per CG Oncology's latest filing, its Receivables stood at $515000.0 for Q3 2025, which was up 27591.24% from $562000.0 recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Receivables registered a high of $562000.0 during Q2 2025, and its lowest value of $92000.0 during Q4 2023.
  • In the last 3 years, CG Oncology's Receivables had a median value of $182000.0 in 2024 and averaged $283714.3.
  • Over the last 5 years, CG Oncology's Receivables had its largest YoY gain of 27591.24% in 2025, and its largest YoY loss of 12549.02% in 2025.
  • Over the past 3 years, CG Oncology's Receivables (Quarter) stood at $92000.0 in 2023, then surged by 48.91% to $137000.0 in 2024, then skyrocketed by 275.91% to $515000.0 in 2025.
  • Its last three reported values are $515000.0 in Q3 2025, $562000.0 for Q2 2025, and $345000.0 during Q1 2025.